2 hrs ago
The Washington Post
Edwards Says Medtronic's CoreValve Should Remain Available
Edwards Lifesciences Corp. Chief Executive Officer Michael Mussallem said the company isn't seeking a complete ban of Medtronic Inc.'s aortic valve in the U.S., even after the company obtained an injunction against it.
Trending on the Topix Network
Tue Apr 15, 2014
Five Star Equities Issues New Research Reports on EW, JASO, TSL and...
Edwards Lifesciences Corp. shares surged 11.00 percent to close at $81.00 a share Monday.
Mon Apr 14, 2014
The Washington Post
U.S. Stocks Rebound After Better Retail Sales, Citigroup Profit
U.S. stocks rebounded from the worst weekly losses in two years, weathering a selloff at the start of the final hour, after data showed retail sales increased the most since 2012 and Citigroup Inc. earnings unexpectedly rose.
The Motley Fool
Why Goodrich Petroleum, WebMD, and Edwards Lifesciences Are Today's 3 Best Stocks
Surprisingly strong U.S. retail sales data this morning lit a spark under the market which helped end the S&P 500's two-day losing streak.
Deutsche Bank Increases Edwards Lifesciences Corp Price Target to $78.00
Deutsche Bank's price target suggests a potential upside of 6.89% from the company's current price.
Medical Device/Diagnostic Ind.
Medronic Loses Latest Battle With Edwards in TAVR War
Edwards Lifesciences won a preliminary injunction limiting sales of Medtronic's CoreValve TAVR product in the United States, but Medtronic has vowed to appeal the ruling.
Movers & Shakers: Citi gains after earnings beat; Edwards up
Shares of Citigroup Inc. rose in premarket trade Monday after its earnings beat expectations, while shares of Edwards Lifesciences Corp. jumped after winning a preliminary injunction.
Edwards Lifesciences up after Medtronic injunction
The injunction, announced Friday, will go into effect in seven business days, the Edwards statement said.
Fri Apr 11, 2014
Federal Court Orders Preliminary Injunction on U.S. Sales of...
Edwards Lifesciences Corporation , the global leader in the science of heart valves and hemodynamic monitoring, announced that the U.S. District Court for the District of Delaware today granted a preliminary injunction limiting the sale of Medtronic's CoreValve system in the United States.
The Orange County Register
Judge rules in Edwards' favor
Irvine heart-valve maker Edwards Lifesciences won a modified victory Friday against its archrival Medtronic Inc. when a federal court judge ordered the Minneapolis-based company to limit but not halt sales of its competing nonsurgical valve in the United States.
California Healthcare Institute (CHI) Adds Five Industry Leaders To Its Board
April 11, 2014 - California Healthcare Institute announced today the election of five senior executives to serve on its board of directors: Jeffrey D. Armstrong, Ph.D., president, California Polytechnic State University, San Luis Obispo; Donald E. Bobo, Jr., corporate vice president, heart valve therapy, Edwards Lifesciences; Kenneth E. Drazan, ... (more)
Wed Apr 09, 2014
Insider Selling: Edwards Lifesciences Corp VP Sells 5,600 Shares of Stock
Edwards Lifesciences Corp VP Huimin Wang sold 5,600 shares of the stock in a transaction dated Monday, April 7th.
Sun Apr 06, 2014
Orange County Register Reports: FDA warns Edwards over broken heart devices
Heart devices made by Edwards Lifesciences Inc. fell apart during surgery, requiring second operations to retrieve the broken bits from inside patients, according to a warning letter by federal regulators citing quality control problems at the company's factory in Draper, Utah.
Fri Apr 04, 2014
The Motley Fool
Better Buy: Medtronic, Inc. vs. Edwards Lifesciences Corp.
The American College of Cardiology meeting is always good for market-moving news, and this year was no different.
Edwards Intuity Elite Valve System Receives Ce Mark
Edwards Lifesciences Corporation , the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received CE Mark for the advanced EDWARDS INTUITY Elite valve system.
Tue Apr 01, 2014
Edwards Lifesciences Corp Price Target Raised to $66.00 at BMO Capital Markets
BMO Capital Markets' price target would suggest a potential downside of 11.02% from the stock's previous close.
Five Star Equities Issues New Research Reports on AMED, BIOF, EW and...
Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns.
Mon Mar 31, 2014
The Washington Post
S&P 500 Index Rises to 5th Quarterly Gain on Fed Support
U.S. stocks climbed, with the Standard & Poor's 500 Index poised for a fifth quarterly gain, as Federal Reserve Chair Janet Yellen signaled continued monetary support and tensions appeared to ease in Ukraine .
Edwards, Medtronic Rise as Valves Show Benefit
Edwards Lifesciences Corp. and Medtronic Inc. rose in New York trading after studies were released that will increase use of their man-made valves that can be inserted into the heart without cracking open the chest.
Sun Mar 30, 2014
Edwards heart valve system tops Medtronic version in small study
The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head study of the two, according to data from a small German trial presented at a major heart meeting on Sunday.